Eloralintide (LY3841136) Canada — 10 mg Lyophilized Vials, Janoshik-Tested

The references section of this page cites 4 primary papers published between 2025 and 2026 — a limited but non-trivial record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.

Eloralintide (LY3841136) is frequently listed as a peptide by suppliers in this market. It is not one. The structure published on this page is the compound's actual chemistry, and research on it should be read against its own class rather than against peptide literature.

Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Eloralintide (LY3841136), set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.

Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.

Verification for Eloralintide (LY3841136) is per lot, not per product. The current 10mg lot ELOR-CA-26G-10 returned 99.81% purity, 12.42 mg measured, 124.2% of the labelled 10 mg, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.

Purity is half the number. It states what fraction of the material in the vial is Eloralintide (LY3841136); it says nothing about how much material is in the vial, and a short-filled vial can return a purity result that is entirely accurate. The figure that answers the second question is measured mass against expected content — for Eloralintide (LY3841136), this lot measured 124.2% of its labelled 10 mg. Both numbers are published for every lot, whichever way they fall.

The lot code printed on the vial matches the code on the certificate for Eloralintide (LY3841136). Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.

Researchers who buy Eloralintide (LY3841136) in Canada through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.

Verify a batch code →

Lyophilized storage

−20 °C long-term; stable at room temperature in transit

After reconstitution

2–8 °C

Light

Protect from UV and direct light

Freeze-thaw

Avoid repeated cycles

Vehicle

Solvent selection depends on the compound; consult the published literature

Format

Lyophilized powder

Eloralintide (LY3841136) is supplied as lyophilized powder. It is not a peptide, and solvent behaviour follows from its own chemistry rather than from the aqueous-vehicle conventions that apply to peptide material — the published literature for this compound is the reference for solvent selection, not a general peptide protocol.

Dry storage below freezing and protection from light are the general controls. As with any lyophilized material, the powder frequently sits as a thin film at the base of the vial and is easy to mistake for an empty vial before inspection.

Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.

Reconstitution calculator →

Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.